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A case of malignant melanoma with a desmoplastic 
recurrence and local lymph node metastasis is repor­
ted. The local relapse and the axillary metastasis 
presented the desmoplastic variant without atypical 
melanocytes that were easily recognised in primary 
lesion. Histological slices were examined by light 
microscopy and iminunohistochemically.
Melanin could not be demonstrated in either recur­
rence or metastasis by histochemical tehnique. Im- 
munoperoxidase staining with anti S-100 protein an­
tibody demonstrated diffuse positivity of spindle 
cells both in relapse and metastasis, allowing the 
assesment of the depth of invasion. All the sections 
were negative for vimentin, desmin and neuron-spe­
cific enolase.
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Malignant melanoma may assume various histologi­
cal and clinical patterns. One of them is known as 
desmoplastic malignant melanoma (DMM), first reco­
gnised in 1971 (1). Melanomas with this histological 
pattern can be easily confused with a large number of 
other spindle-cell reactions and neoplasms.
DMM shows a distinct propensity toward repeated 
local recurrence but may also give rise to systemic 
metastases and death. In this report, a case of DMM and 
the immunostain properties of the DMM tissue are 
described.
CASE REPORT
A 62-year-old woman noticed that a mole on her left 
forearm had enlarged together with the nodule beneath 
the initial lesion. The excision was performed in April 
1986. A pigmented lesion 6 mm in diameter overlying 
the grayish-white nodule of fibrous appearance was 
noted.
The centre of the pigmented lesion was ulcerated. 
Near the edges of ulceration, small groups of atypical 
melanocytes were observed both in epidermis and in the 
junctional zone. Toward the depth of the lesion, there 
was a slight transition between atypical melanocytes of 
spindle or epitheloid appearance and fibroblast-like
cells with abundant collagen stroma performing the 
toriform pattern. The lesion was not sharply demarca­
ted from the subcutaneous fat tissue. It was diagnosed 
as malignant melanoma (figure 1).
In July 1987 the same patient was readmitted to 
hospital because of a hard nodule arising at the site of 
previous excision. Wide excision was performed once 
again, revealing a grayish nodule 25 mm in diameter, 
i filtrating subcutaneous tissue extensively. A diagno­
sis of DMM was made on review of the previous biopsy 
(figure 2).
In October 1987 the patient palpated a hard nodule 
in her left axilla, and a smaller one on the site of the two 
earlier biopsies. Histological examination of a small 
nodule 4 mm in diameter revealed granulomatous in- 
flamation with the multinucleated cells of the foreign- 
-body type around the surgical material, with no tu­
mour regrowth. However, axillary biopsy of a hard 
infiltrating grayish nodule 53 mm in diameter was 
diagnosed as a metastasis of the DMM. Histological 
appearance of the axillary lesion was that of the recur­
rence, with long spindle cells occasionally having enlar­
ged hyperchromatic nuclei, with no melanin content, in 
a background of proliferating connective tissue with 
abundant collagen (figure 3). After a year, the patient 
was lost to follow-up.
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FIGURE 3.
Biopsy of the recurrence. Elongated to oval nuclei with co­
arse chromatin. Melanin pigment is not visible in the cyto­
plasm of the cells. Haematoxylin-eosin, 100X 
SLIKA 3.
Biopsija recidivne promjene. Izdužene i ovalne jezgre s 
raspršenim kromatinom. Pigment melanin ne vidi se u cito- 
plazmama stanica. Hematoksilin-eozin, 100X
FIGURE 1.
Biopsy of the primary lesion. Atypical melanocytes are pre 
sent near the edges of ulceration. Haematoxylin-eosin, 8X 
SLIKA 1.
Biopsija prve promjene. Atipični melanociti nalaze se uz 
rubove ulceracije. Hematoksilin-eozin, 8X
FIGURE 2.
Biopsy of the recurrence. Elongated fibroblast-like cells 
surrounded by abundant collagen. Haematoxylin-eosin, 25X 
SLIKA 2.
Biopsija recidivne promjene. Izdužene stanice nalik fibro- 
blastima okružene su obilnim kolagenom. Hematoksilin-eo­
zin, 25X
Reviewing the biopsies, paraffin sections of the tu­
mour were stained by the Fontana method to delineate 
melanin granules. Additional paraffin sections of the 
tumour were stained for S-100 protein, vimentin, de- 
smin and neuron-specific enolase (NSE). Melanin 
stains of all the examinated sections were negative. 
Spindle cells both in relapse and metastasis were clearly 
positive with S-100 protein, and negative for vimentin, 
desmin and NSE. The S-100 protein immunostain pro­
ved to be useful in determining the depth of the lesion 
and the nature of fibroblast-like, elongated cells.
DISCUSSION
In 1971, Conley et al. (6) described an uncommon 
variant of malignant melanoma they termed »desmo­
plastic melanoma«. Those were seven subcutaneous 
non-pigmented, collagenizing, fibrosarcoma-like tu­
mours that were associated with overlying inconspi­
cuous, intraepidermal aggregations of atypical maleno- 
cytes. Desmoplasia may be defined as fibroconnective 
tissue proliferation of variable degree often found asso­
ciated with highly invasive epithelial tumours (such as 
carcinomas of the breast, pancreas and linitis plastica 
of the stomach (13,25)), in which it has been implicated 
in the benign host reaction to the malignant cells (18).
Desmoplastic malignant melanomas were later sub­
divided into three groups on the basis of the clinicopa- 
thological features at the time of the first biopsy (14) : 
1) desmoplastic melanoma with an atypical intraepider­
mal melanocytic component - classical DMM, 2) desmo­
plastic melanomas without a demonstrated atypical 
intraepidermal melanocytic component - de novo 
DMM, and 3) nerve-centered DMM, either with or 
without an intraepidermal melanocytic component. 
While the latter were histologically indistinguishable 
from the classical DMM, the clinically apparent and 
grossly visible nerve enlargement created the impes- 
sion of a primary nerve tumour (14).
Conley’s concept was extended by Reed and Leonard 
(21), who observed schwannian appearance of the ame- 
lanotic spindled melanocytes and described it under the 
term »neurotropic« melanoma. This type of melanoma
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usually occurs on the face, particculary the lips, and 
exhibits a marked tendency for peripheral nerve inva­
sion (7,21).
DMM are usually located in the head and neck area 
(6,9,14,17), including the eye-lid (24). The anatomical 
locations less frequently involved are limbs, trunk and 
anus (1,6,27).
The reported patients’ ages vary from 13 to 91 years, 
with the peak in the seventh decade (6,9,14). The male 
patients are affected slightly more frequently - an ap­
proximate male to female ratio is 1.5:1 (9,14).
The relationship of the superficial, melanocytic, pre­
cursor lesion (lentigo maligna, acral-lentiginous mela­
noma), at least in most cases, including our own, with 
a deeper, amelanotic spindled component has been 
stressed (6,9,17,21,22,27). It has been suspected that 
tumour growth is triggered by the sun exposure (4,5). 
An association with ionizing radiation has also been 
reported (14). Jain and Allen (1989) (14) believed thet 
the observed clinicopathological features of DMM occu- 
red as a result of the following chain of events: sunlight 
or ionizing radiation produce lentigo maligna or mela­
nocytic dysplasia in epidermis. Some of these, over the 
years, may develop nodular, epitheloid or spindle cell 
malignant melanomas, with or without melanin pro­
duction. A very small minority proceed along different 
growth pathways - after developing the malignant po­
tential in the epidermis, the neoplastic nevus cells chan­
ge their appearance so they resemble light microscopi­
cal features of fibroblastic, histiocytic, smooth muscle, 
Schwann’s, endothelial or epithelial cells.
The desmoplastic response and the nature of the 
spindle cells were believed by some authors to be the 
host reaction to the growth of the tumour (17), analo­
gous to the atypical but otheiwise benign fibroblasts 
seen in the inflammatory pseudosarcomatous lesion 
after ionizing radiation (20), trauma (15), squamous cell 
carcinoma (18), or other cutaneous injury. A similar 
explanation has been proposed to account for the spin­
dle cells in desmoplastic nevus (3). Fibrosis and colla- 
genization of the stroma have also been mentioned in 
connection with benign nevi in older age groups (2,3), 
or as a feature of the cellular and of the malignant blue 
nevus (8,11,16,19,23).
However, ultrastructural and immunohistochemical 
findings indicate that the spindle cells of the DMM 
possess some melanocytic features. These are the occa­
sional presence of premelanosomes (6,13), melanoso- 
mes (13), and macular desmosomes (26), observed ear­
lier in both melanotic and amelanotic melanomas (10, 
12), as well as the S-100 protein (9,13,14,22,24,28), and 
desmin (22) positive stain. All these findings, together 
with observations of neuroma-like qualities in DMM 
(21), neurosarcomatous transformation (7), simulated 
Schwann’s cell (7,21,27) fibroblastic and myofibrobla-
stic differentiation (13,26,27), suggest that melanoma 
cells may undergo a transformation or metaplasia (4) 
and differentiate along alternate pathways, so produ­
cing the desmoplastic component. Such metaplasia in 
malignant melanoma is expected, considering the neu­
tral crest derivation of nevus cells (7,14,28).
DMM may be misdiagnosed as some mesenchymal 
proliferations (fibromatosis (6,14), hypertrophied scar 
and keloid fibroma (6,25,26), desmoplastic nevus (3,27), 
benign and malignant fibrous histiocytoma (6,9, 26), 
atypical fibroxantoma (13,14,17,27), dermatofibrosar- 
coma protuberans (13,17), fibrosarcoma (6,9,13,14,17), 
leiomyoma and leiomyosarcoma (9,13)) as well as be­
nign and malignant neurinoma, (9,13,14) neurofibroma 
(9,13,14) neurofibrosarcoma (9,13) and, finally, mali­
gnant nerve-sheat tumours (9). Additional malignant 
lesions within the differntial diagnosis are spindle cell 
squamous carcinoma (6,13,27) and renal cell carcinoma 
metastases (9).
All these lesions may be impossible to differentiate 
from non-pigmented DMM by light microscopy diagno­
stic. In the absence of an obvious associated melanoma, 
careful attention to the basal layer of the epidermis may 
reveal melanocytic dysplasia (27). We succededin asses­
sing the right diagnosis only according to the first biopsy 
with clearly visible melanocytic atypia. Staining with 
S-100 is helpful in assessment of the level of invasion 
(13), and is used to exclude fibrohistiocytic and epithe­
loid lesions (9,13,22). However, tumours of the neural 
origin cannot be excluded in this way (13,22). Clinically, 
DMM are deeply invasive lesions that frequently recur 
and metastasize. Relapses and metastases may have 
istological appearance of both classical and desmopla­
stic (our case) MM (6). Walsh et al. concluded that with 
desmoplasia comes a more favourable pattern of biolo­
gical behaviour (27). in contrast to others who stated 
that DMM is a highly malignant lesion (9,24). Although 
there were occasional »unexpectedly good responses to 
radiotherapy and chemotherapy« (14), radical surgical 
excision appears to offer the best results. The mortality 
rates are reported to be 36% (14) up to 66% (22).
As a conclusion, it is most important for the patho­
logist and clinical to be aware of this rare variant of 
malignant melanoma.
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Sažetak
DEZMOPLASTIČNI MALIGNI MELANOM  
Prikaz bolesnika, imunohistokemijske analize i pregled literature
Branko Dmitrović i Ante Trošić  
Odjel za patologiju Opće bolnice Osijek
Prikazana je 62-godišnja bolesnica kojoj je s lijeve 
podlaktice odstranjen maligni melanom s izraženom 
dezmoplastičnom komponentom. Tumor je na povr­
šini bio ulceriran, uz rubove ulceracije opažene su 
nakupine atipičnih melanocita, dok su u dubljim 
dijelovima vretenaste tumorske stanice nalikovale 
benignim fibroblastima. 15 mjeseci nakon prethodne 
ekscizije odstranjen je recidiv koji je bio građen od 
vretenastih stanica nalik benignim fibroblastima, a 
nije pronađen nijedan atipični melanocit »klasičnog 
izgleda«. Ispravna dijagnoza postavljena je jedino na 
osnovi nalaza prethodne biopsije. Poslije 3 mjeseca 
bolesnica je napipala povećan limfni čvor u lijevom 
pazuhu koji je kirurški odstranjen. Histološkim pre­
gledom opaženo je tkivo identičnog izgleda poput 
onoga u recidivu, koje je izbrisalo normalnu građu 
limfnog čvora, s očitim znakovima invazije okolnog 
masnog tkiva. Histokemijskim metodama u recidivu 
i metastazi nije se mogao dokazati melanin. Vretena­
ste tumorske stanice prikazale su difuznu reaktivnost 
nakon primjene antitijela na S-100 protein, a nakon 
primjene antitijela na vimentin, desni in i neuron- 
-specifičnu enolazu (NSE), pozitivna imunohistoke- 
mijska reakcija nije opažena.
Dezmoplastični maligni melanom (DMM) opisan je 
kao zaseban entitet 1971. godine. Dok se u uobičaje­
nim okolnostima iz prekursorskih kožnih melanocit- 
nih lezija (lentigo maligna, melanocitna displazija) 
mogu razviti maligni melanomi dobro poznatog, 
»klasičnog«, histološkog izgleda, u malom broju slu­
čajeva neoplastične stanice mijenjaju svoj izgled na­
likujući fibroblastima, histiocitima, glatkim mišić­
nim stanicama ili Švanovim stanicama.
DMM histološkim izgledom sliči brojnim mezenhim- 
skim proliferacijama (fibromatoze, hipertrofični  
ožiljak, fibrom, dezmoplastični nevus, benigni i ma­
ligni fibrozni histiocitom-dermatofibrom, atipični  
fibroksantom, dermatofibrosarkoma protuberans, 
fibrosarkom, leiomiom i leiomiosarkom), benignom 
i malignom neurinomu, neurofibromu, neurofibro- 
sarkomu, pa i vretensto-staničnim oblicima ploča­
stog karcinoma ili metastazama karcinoma bubre­
žnih stanica.
Diferencijalna dijagnoza DMM izuzetno je teška. Pri­
mjena imunohistokemijske reakcije s antitijelima na 
S-100 protein može biti od pomoći prilikom procjene 
dubine i porijekla lezije (isključuju se fibrohistiocit-  
ne i epitelne neoplazije).
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